bioMerieux The MDA system with MDA Antithrombin III MDA Heparin Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
The MDA system with MDA Antithrombin III MDA Heparin
Brand
bioMerieux
Lot Codes / Batch Numbers
All product numbers
Products Sold
All product numbers
bioMerieux is recalling The MDA system with MDA Antithrombin III MDA Heparin due to The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens.
Recommended Action
Per FDA guidance
Consignees were initially notified by letter on June 11, 2004. A follow up letter was sent to consignees, via Fedex on July 9, 2004.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026